Description

Semaglutide 10mg: High-Yield GLP-1 Receptor Agonist

Semaglutide 10mg is the industry-defining GLP-1 receptor agonist that set the benchmark for modern metabolic research. By mimicking the natural GLP-1 hormone, it pioneered a new era of weight management and glycemic control, serving as the essential precursor to dual-agonists like Tirzepatide.

Why Research Semaglutide?

• Targeted GLP-1 Activation: Focuses exclusively on the Glucagon-like peptide-1 receptor to stimulate insulin secretion and suppress appetite.

• Extensive Clinical Data: Backed by the landmark STEP Clinical Trial Program, showing sustained weight loss and cardiovascular risk reduction.

• Metabolic Regulation: Highly effective for researching long-term improvements in HbA1c levels and overall metabolic health.

• High-Yield Research: The 10mg format is ideal for extended longitudinal studies or multi-subject research protocols.

Quick Specifications

• Class: GLP-1 Receptor Agonist

• Format: 10mg Lyophilized Peptide (High Purity)

• Administration: Weekly subcutaneous injection protocol

• Clinical Status: FDA-approved for T2DM and Chronic Weight Management

The Gold Standard Benchmark

As the most studied peptide in its class, Semaglutide remains the critical “control” for researchers evaluating next-generation “Triple G” agonists like Retatrutide. Its reliable and predictable pharmacological profile makes it a staple in any metabolic laboratory.

Notice: This product is intended for laboratory research use only. It is not for human consumption or diagnostic use.